Sponsor Collaborators Module
The Sponsor Collaborators Module contains information about the sponsors and collaborators involved in the clinical trial. This includes lead sponsor details, responsible party information, investigator information, and collaborator organizations that are supporting or conducting the study.
Sponsor Collaborators Module path is as follows:
Study -> Protocol Section -> Sponsor Collaborators Module -> Collaborators
Sponsor Collaborators Module
Ignite Creation Date:
2025-12-25 @ 2:22 AM
Ignite Modification Date:
2025-12-26 @ 12:54 AM
NCT ID:
NCT03011034
Responsible Party Type:
SPONSOR
Study:
NCT03011034
Study Brief:
Study to Separately Evaluate the Activity of Talacotuzumab (JNJ-56022473) or Daratumumab in Transfusion-Dependent Participants With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) Who Are Relapsed or Refractory to Erythropoiesis-Stimulating Agent (ESA) Treatment
Protocol Section:
NCT03011034
Collaborators (If Any):